Background: Recent studies have showed conservative management in selective patients with borderline and malignant ovarian tumors is safe; therefore this management is considered in patients with ovarian tumor who desire to preserve fertility. Objective: This study has been performed to evaluate the clinical outcome and fertility in patients with ovarian tumors who were treated conservatively. Materials and Methods: All patients who were treated conservatively (preservation of uterus and at least one ovary) or were on follow-up and had recurrence were evaluated in Vali-e-Asr Hospital during 2000-2004. Results: Among 410 patients with ovarian tumors, 60 were treated conservatively. Age range was 13-34 years. Twenty-six of patients (43....
Malignant ovarian germ cell tumours (MOGCT) principally occur in girls and young women and are gener...
The treatment of borderline ovarian tumours has been similar to that for their invasive counterparts...
Aim and objectives: to evaluate the remote outcomes of patients with BOT after radical and conservat...
Background: Recent studies have showed conservative management in selective patients with borderlin...
Conservative management of at least part of both the ovary and uterus can be proposed in patients wi...
Borderline ovarian tumours account for 10-15% of all ovarian cancers, and there have been numerous s...
OBJECTIVE: To assess the safety of fertility-sparing treatment and the remaining chance of childbear...
Objective This study was performed to assess the feasibility of conservative treatment for stage II ...
OBJECTIVE: To evaluate the fertility and survival outcomes in young women with borderline ovarian tu...
Background Ovarian cancer may appear in young women during their reproductive age. As a result of la...
Gynecol Oncol. 2006 Jan;100(1):185-91. Epub 2005 Oct 10. Conservative surgery for borderline ovaria...
SummaryObjectiveOvarian tumors of borderline malignancy are not as aggressive as, and tend to occur ...
Objective: The aim was to evaluate the outcome of fertility-sparing treatment in ovarian borderline ...
Background In invasive ovarian cancer, fertility saving Surgery is confined to early-stage and low-g...
: Borderline ovarian tumors (BOTs) account for approximately 15% of all epithelial ovarian cancers. ...
Malignant ovarian germ cell tumours (MOGCT) principally occur in girls and young women and are gener...
The treatment of borderline ovarian tumours has been similar to that for their invasive counterparts...
Aim and objectives: to evaluate the remote outcomes of patients with BOT after radical and conservat...
Background: Recent studies have showed conservative management in selective patients with borderlin...
Conservative management of at least part of both the ovary and uterus can be proposed in patients wi...
Borderline ovarian tumours account for 10-15% of all ovarian cancers, and there have been numerous s...
OBJECTIVE: To assess the safety of fertility-sparing treatment and the remaining chance of childbear...
Objective This study was performed to assess the feasibility of conservative treatment for stage II ...
OBJECTIVE: To evaluate the fertility and survival outcomes in young women with borderline ovarian tu...
Background Ovarian cancer may appear in young women during their reproductive age. As a result of la...
Gynecol Oncol. 2006 Jan;100(1):185-91. Epub 2005 Oct 10. Conservative surgery for borderline ovaria...
SummaryObjectiveOvarian tumors of borderline malignancy are not as aggressive as, and tend to occur ...
Objective: The aim was to evaluate the outcome of fertility-sparing treatment in ovarian borderline ...
Background In invasive ovarian cancer, fertility saving Surgery is confined to early-stage and low-g...
: Borderline ovarian tumors (BOTs) account for approximately 15% of all epithelial ovarian cancers. ...
Malignant ovarian germ cell tumours (MOGCT) principally occur in girls and young women and are gener...
The treatment of borderline ovarian tumours has been similar to that for their invasive counterparts...
Aim and objectives: to evaluate the remote outcomes of patients with BOT after radical and conservat...